Korro Bio, Inc. financial statements
Korro Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 6.39M | 10-K |
| Net income | −USD 117.26M | 10-K |
| Cash and equivalents | USD 21.82M | 10-Q |
| Total debt | USD 43.49M | EODHD |